These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38999819)

  • 1. Abnormality in Peripheral and Brain Iron Contents and the Relationship with Grey Matter Volumes in Major Depressive Disorder.
    Liang W; Zhou B; Miao Z; Liu X; Liu S
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
    Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
    Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain structural alterations in MDD patients with gastrointestinal symptoms: Evidence from the REST-meta-MDD project.
    Liu PH; Li Y; Zhang AX; Sun N; Li GZ; Chen X; Bai TJ; Bo QJ; Chen GM; Chen NX; Chen TL; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Li T; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yao JS; Yao SQ; Yin YY; Yuan YG; Zhang H; Zhang L; Zhang ZJ; Zhou RB; Zhou YT; Zhu JJ; Zou CJ; Si TM; Zuo XN; Yan CG; Zhang KR
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110386. PubMed ID: 34119573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
    Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
    EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal brain volume changes in major depressive disorder.
    Yüksel D; Engelen J; Schuster V; Dietsche B; Konrad C; Jansen A; Dannlowski U; Kircher T; Krug A
    J Neural Transm (Vienna); 2018 Oct; 125(10):1433-1447. PubMed ID: 30167933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural foundation of the diathesis-stress model: longitudinal gray matter volume changes in response to stressful life events in major depressive disorder and healthy controls.
    Thomas-Odenthal F; Ringwald K; Teutenberg L; Stein F; Alexander N; Bonnekoh LM; Brosch K; Dohm K; Flinkenflügel K; Grotegerd D; Hahn T; Jansen A; Leehr EJ; Meinert S; Pfarr JK; Renz H; Schürmeyer N; Stief T; Straube B; Thiel K; Usemann P; Winter A; Krug A; Nenadić I; Dannlowski U; Kircher T
    Mol Psychiatry; 2024 Sep; 29(9):2724-2732. PubMed ID: 38553539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Mohammadi S; Ghaderi S; Fatehi F
    Brain Behav; 2024 Oct; 14(10):e70093. PubMed ID: 39415615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.
    Li J; Zhang Q; Zhang N; Guo L
    J Diabetes Res; 2020; 2020():7242530. PubMed ID: 33062715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different spatial patterns of brain atrophy and global functional connectivity impairments in major depressive disorder.
    Zhuo C; Zhu J; Wang C; Qu H; Ma X; Qin W
    Brain Imaging Behav; 2017 Dec; 11(6):1678-1689. PubMed ID: 27766588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep grey matter iron accumulation in alcohol use disorder.
    Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
    Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder.
    Wu Y; Kong L; Yang A; Xin K; Lu Y; Yan X; Liu W; Zhu Y; Guo Y; Jiang X; Zhou Y; Sun Q; Tang Y; Wu F
    Neuroimage Clin; 2023; 37():103341. PubMed ID: 36739789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
    Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
    J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociative changes in gray matter volume following electroconvulsive therapy in major depressive disorder: a longitudinal structural magnetic resonance imaging study.
    Xu H; Zhao T; Luo F; Zheng Y
    Neuroradiology; 2019 Nov; 61(11):1297-1308. PubMed ID: 31410504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The left dorsolateral prefrontal cortex volume is reduced in adults reporting childhood trauma independent of depression diagnosis.
    Lu S; Xu R; Cao J; Yin Y; Gao W; Wang D; Wei Z; Hu S; Huang M; Li L; Xu Y
    J Psychiatr Res; 2019 May; 112():12-17. PubMed ID: 30831535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey matter volume abnormalities in the first depressive episode of medication-naïve adult individuals: a systematic review of voxel based morphometric studies.
    Amidfar M; Quevedo J; Z Réus G; Kim YK
    Int J Psychiatry Clin Pract; 2021 Nov; 25(4):407-420. PubMed ID: 33351672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder.
    Lu Y; Liang H; Han D; Mo Y; Li Z; Cheng Y; Xu X; Shen Z; Tan C; Zhao W; Zhu Y; Sun X
    Neuroimage Clin; 2016; 11():658-666. PubMed ID: 27222797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescents with current major depressive disorder show dissimilar patterns of age-related differences in ACC and thalamus.
    Hagan CC; Graham JM; Tait R; Widmer B; van Nieuwenhuizen AO; Ooi C; Whitaker KJ; Simas T; Bullmore ET; Lennox BR; Sahakian BJ; Goodyer IM; Suckling J
    Neuroimage Clin; 2015; 7():391-9. PubMed ID: 25685707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated miR-16-2 in peripheral blood is positively correlated with decreased bilateral insula volume in patients with major depressive disorder.
    Wang Y; Yan Y; Wei J; Yang X; Wang M; Zhao L; Dou Y; Du Y; Wang Q; Ma X
    J Affect Disord; 2023 Oct; 338():137-143. PubMed ID: 37245547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.